A Harvard researcher, a longevity doctor and Bar Refaeli are chasing the future of sk

Bar Refaeli is entering the booming longevity industry with a new Israeli startup that aims to transform the anti-aging market by moving beyond traditional skincare products and delivering active ingredients directly into skin cells. Factor X, founded by Refaeli alongside physician Dr. Inbal Gat, Harvard-trained scientist Dr. Shira Orr and entrepreneur Eran Orr, announced its launch after completing a pre-Seed funding round and while raising a Seed round to expand development. The company is estimated to have raised a few million dollars to date. The startup is developing a cellular delivery platform based on longevity science that it says can transport biological signals directly into skin cells. Unlike conventional cosmetics, which largely rely on ingredients designed to penetrate the outer layers of skin, Factor X is attempting to influence cellular processes from within.